Dried Plasma

  • Mouayyad Zaza
  • Kyle J. Kalkwarf
  • John B. Holcomb


Dried plasma provides an alternative for early plasma transfusion in the resuscitation of hemorrhagic shock in environments where fresh frozen plasma is not immediately available. It is produced by freeze-drying or spray-drying liquid or thawed plasma. It is shelf-stable for prolonged periods, can be stored at room temperature, and is easy to transport, reconstitute, and administer. It was widely used in WWII but fell out of favor due to the risk of infectious disease transmission. The German and French experiences with lyophilized plasma are the most extensive and show a good track record of efficacy and safety. Recent studies show many beneficial effects of dried plasma in the treatment of shock in large animal models. Currently, no FDA-licensed product is available in the USA, but several are under development.


Lyophilized plasma Dried plasma Freeze-dried plasma Spray-dried plasma Battlefield transfusion Point-of-injury transfusion Prehospital transfusion 



Damage control resuscitation


Freeze-dried plasma


Fresh frozen plasma


French lyophilize plasma


Lyophilized plasma


Red blood cells




Spray-dried plasma


Traumatic brain injury




  1. 1.
    Holcomb J. Transport time and preoperating room hemostatic interventions are important. Crit Care Med. 2018;46(3):447–53.PubMedCrossRefPubMedCentralGoogle Scholar
  2. 2.
    Alarhayem A, Myers J, Dent D, Liao L, Muir M, Mueller D, et al. Time is the enemy: mortality in trauma patients with hemorrhage from torso injury occurs long before the “golden hour”. Am J Surg. 2016;212(6):1101–5.CrossRefGoogle Scholar
  3. 3.
    Holcomb J, del Junco D, Fox E, Wade C, Cohen M, Schreiber M, et al. The prospective, observational, multicenter, major trauma transfusion [PROMMTT] study. JAMA Surg. 2013;148(2):127.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Holcomb J, Jenkins D, Rhee P, Johannigman J, Mahoney P, Mehta S, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma. 2007;62(2):307–10.CrossRefGoogle Scholar
  5. 5.
    Kashuk JL, Moore EE, Millikan JS, Moore JB. Major abdominal vascular trauma—a unified approach. J Trauma. 1982;22(8):672–9.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Bickell W, Wall M, Pepe P, Martin R, Ginger V, Allen M, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med. 1994;331(17):1105–9.CrossRefGoogle Scholar
  7. 7.
    Holcomb J, Wade C, Michalek J, Chisholm G, Zarzabal L, Schreiber M, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg. 2008;248(3):447–58.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Beecher H. Preparation of battle casualties for surgery. Ann Surg. 1945;121(6):769–92.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma. 2003;54(6):1127–30.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    MacLeod J, Lynn M, McKenney M, Cohn S, Murtha M. Early coagulopathy predicts mortality in trauma. J Trauma. 2003;55(1):39–44.PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Hess J, Lindell A, Stansbury L, Dutton R, Scalea T. The prevalence of abnormal results of conventional coagulation tests on admission to a trauma center. Transfusion. 2009;49(1):34–9.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Maegele M, Lefering R, Yucel N, Tjardes T, Rixen D, Paffrath T, et al. Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury. 2007;38(3):298–304.CrossRefGoogle Scholar
  13. 13.
    Pidcoke H, Aden J, Mora A, Borgman M, Spinella P, Dubick M, et al. Ten-year analysis of transfusion in operation Iraqi freedom and operation enduring freedom. J Trauma Acute Care Surg. 2012;73:S445–52.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Holcomb J, Pati S. Optimal trauma resuscitation with plasma as the primary resuscitative fluid: the surgeon’s perspective. Hematology. 2013;2013(1):656–9.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Borgman M, Spinella P, Perkins J, Grathwohl K, Repine T, Beekley A, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma. 2007;63(4):805–13.CrossRefGoogle Scholar
  16. 16.
    Pusateri A, Given M, Schreiber M, Spinella P, Pati S, Kozar R, et al. Dried plasma: state of the science and recent developments. Transfusion. 2016;56:S128–39.PubMedCrossRefGoogle Scholar
  17. 17.
    Spinella P, Dunne J, Beilman G, O’Connell R, Borgman M, Cap A, et al. Constant challenges and evolution of US military transfusion medicine and blood operations in combat. Transfusion. 2012;52(5):1146–53.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Simmons J, White C, Eastridge B, Mace J, Wade C, Blackbourne L. Impact of policy change on US Army combat transfusion practices. J Trauma. 2010;69(Supplement):S75–80.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Holcomb J, Tilley B, Baraniuk S, Fox E, Wade C, Podbielski J, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313(5):471–82.PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Radwan Z, Bai Y, Matijevic N, del Junco D, McCarthy J, Wade C, et al. An emergency department thawed plasma protocol for severely injured patients. JAMA Surg. 2013;148(2):170.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Shackelford S, del Junco D, Powell-Dunford N, Mazuchowski E, Howard J, Kotwal R, et al. Association of prehospital blood product transfusion during medical evacuation of combat casualties in Afghanistan with acute and 30-day survival. JAMA. 2017;318(16):1581.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Holcomb J, Donathan D, Cotton B, del Junco D, Brown G, Wenckstern T, et al. Prehospital transfusion of plasma and red blood cells in trauma patients. Prehosp Emerg Care. 2014;19(1):1–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Nelson A, Statkevicius S, Schött U, Johansson P, Bentzer P. Effects of fresh frozen plasma, Ringer’s acetate and albumin on plasma volume and on circulating glycocalyx components following haemorrhagic shock in rats. Intensive Care Med Exp. 2016;4(1):6.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Kozar R, Pati S. Syndecan-1 restitution by plasma after hemorrhagic shock. J Trauma Acute Care Surg. 2015;78:S83–6.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Peng Z, Pati S, Potter D, Brown R, Holcomb J, Grill R, et al. Fresh frozen plasma lessens pulmonary endothelial inflammation and hyperpermeability after hemorrhagic shock and is associated with loss of syndecan 1. Shock. 2013;40(3):195–202.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Kozar R, Peng Z, Zhang R, Holcomb J, Pati S, Park P, et al. Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth Analg. 2011;112(6):1289–95.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Halaweish I, Bambakidis T, He W, Linzel D, Chang Z, Srinivasan A, et al. Early resuscitation with fresh frozen plasma for traumatic brain injury combined with hemorrhagic shock improves neurologic recovery. J Am Coll Surg. 2015;220(5):809–19.PubMedCrossRefGoogle Scholar
  28. 28.
    Hwabejire J, Imam A, Jin G, Liu B, Li Y, Sillesen M, et al. Differential effects of fresh frozen plasma and normal saline on secondary brain damage in a large animal model of polytrauma, hemorrhage and traumatic brain injury. J Trauma Acute Care Surg. 2013;75(6):968–75.PubMedCrossRefGoogle Scholar
  29. 29.
    Jin G, deMoya M, Duggan M, Knightly T, Mejaddam A, Hwabejire J, et al. Traumatic brain injury and hemorrhagic shock: evaluation of different resuscitation strategies in a large animal model of combined insults. Shock. 2012;38(1):49–56.PubMedCrossRefGoogle Scholar
  30. 30.
    Imam A, Jin G, Sillesen M, Dekker S, Bambakidis T, Hwabejire J, et al. Fresh frozen plasma resuscitation provides neuroprotection compared to normal saline in a large animal model of traumatic brain injury and polytrauma. J Neurotrauma. 2015;32(5):307–13.PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Chang R, Folkerson L, Sloan D, Tomasek J, Kitagawa R, Choi H, et al. Early plasma transfusion is associated with improved survival after isolated traumatic brain injury in patients with multifocal intracranial hemorrhage. Surgery. 2017;161(2):538–45.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Hess J, Lelkens C, Holcomb J, Scalea T. Advances in military, field, and austere transfusion medicine in the last decade. Transfus Apher Sci. 2013;49(3):380–6.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Nessen S, Eastridge B, Cronk D, Craig R, Berséus O, Ellison R, et al. Fresh whole blood use by forward surgical teams in Afghanistan is associated with improved survival compared to component therapy without platelets. Transfusion. 2013;53:107S–13S.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Cotton B, Reddy N, Hatch Q, LeFebvre E, Wade C, Kozar R, et al. Damage control resuscitation is associated with a reduction in resuscitation volumes and improvement in survival in 390 damage control laparotomy patients. Ann Surg. 2011;254(4):598–605.PubMedCrossRefGoogle Scholar
  35. 35.
    Hmel P, Kennedy A, Quiles J, Gorogias M, Seelbaugh J, Morrissette C, et al. Physical and thermal properties of blood storage bags: implications for shipping frozen components on dry ice. Transfusion. 2002;42(7):836–46.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Inaba K. Freeze-dried plasma. J Trauma. 2011;70:S57–8.PubMedCrossRefGoogle Scholar
  37. 37.
    Schmidt P. The plasma wars: a history. Transfusion. 2012;52:2S–4S.PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Elliott J. A preliminary report of a new method of blood transfusion. South Med Surg. 1936;97:7–10.Google Scholar
  39. 39.
    Elliott J, Nesset NM. A report on the use of a perfected evacuated unit for blood transfusion. South Med Surg. 1940;102:303–5.Google Scholar
  40. 40.
    Kendrick D, Heaton L, Coates J, McFetridge E. Blood program in World War II. Washington, DC: Office of the Surgeon General, Dept. of the Army; 1989. p. 266.Google Scholar
  41. 41.
    Maroney E. A study of experimental and clinical shock with special reference to its treatment by the intravenous injection of preserved plasma. Ann Surg. 1938;108(2):178–93.CrossRefGoogle Scholar
  42. 42.
    Watson J, Pati S, Schreiber M. Plasma transfusion: history, current realities, and novel improvements. Shock. 2016;46(5):468–79.CrossRefGoogle Scholar
  43. 43.
    Stetten D. The blood plasma for Great Britain project. Bull N Y Acad Med. 1941;17(1):27–38.PubMedPubMedCentralGoogle Scholar
  44. 44.
    Strumia MM, Wagner JA, Monaghan JF. The intravenous use of serum and plasma, fresh and preserved. Ann Surg. 1940;111:623–9.PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Bux J, Dickhörner D, Scheel E. Quality of freeze-dried [lyophilized] quarantined single-donor plasma. Transfusion. 2013;53(12):3203–9.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Booth G, Lozier J, Nghiem K, Clibourn D, Klein H, Flegel W. Spray: single-donor plasma product for room temperature storage. Transfusion. 2011;52(4):828–33.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Stramer S, Glynn S, Kleinman S, Strong D, Caglioti S, Wright D, et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid–amplification testing. N Engl J Med. 2004;351(8):760–8.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Liumbruno G, Franchini M. Solvent/detergent plasma: pharmaceutical characteristics and clinical experience. J Thromb Thrombolysis. 2014;39(1):118–28.CrossRefGoogle Scholar
  49. 49.
    Wollowitz S. Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma. Semin Hematol. 2001;38(4, Suppl 11):4–11.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Hambleton J, Wages D, Radu-Radulescu L, Adams M, MacKenzie M, Shafer S, et al. Pharmacokinetic study of FFP photochemically treated with amotosalen (S-59) and UV light compared to FFP in healthy volunteers anticoagulated with warfarin. Transfusion. 2002;42(10):1302–7.PubMedCrossRefGoogle Scholar
  51. 51.
    Keil S, Bengrine A, Bowen R, Marschner S, Hovenga N, Rouse L, et al. Inactivation of viruses in platelet and plasma products using a riboflavin-and-UV-based photochemical treatment. Transfusion. 2015;55(7):1736–44.PubMedCrossRefGoogle Scholar
  52. 52.
    Rock G. A comparison of methods of pathogen inactivation of FFP. Vox Sang. 2011;100(2):169–78.PubMedCrossRefPubMedCentralGoogle Scholar
  53. 53.
    McCully S, Martin D, Cook M, Gordon N, McCully B, Lee T, et al. Effect of ascorbic acid concentrations on hemodynamics and inflammation following lyophilized plasma transfusion. J Trauma Acute Care Surg. 2015;79(1):30–8.PubMedCrossRefGoogle Scholar
  54. 54.
    Sailliol A, Martinaud C, Cap A, Civadier C, Clavier B, Deshayes A, et al. The evolving role of lyophilized plasma in remote damage control resuscitation in the French Armed Forces Health Service. Transfusion. 2013;53:65S–71S.PubMedPubMedCentralCrossRefGoogle Scholar
  55. 55.
    Spoerke N, Zink K, Cho SD, Differding J, Muller P, Karahan A, Sondeen J, et al. Lyophilized plasma for resuscitation in a swine model of severe injury. Arch Surg. 2009;144(9):829.PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    Lee T, Van P, Spoerke N, Hamilton G, Cho S, Watson K, et al. The use of lyophilized plasma in a severe multi-injury pig model. Transfusion. 2013;53:72S–9S.PubMedCrossRefPubMedCentralGoogle Scholar
  57. 57.
    Van P, Hamilton G, Kremenevskiy I, Sambasivan C, Spoerke N, Differding J, et al. Lyophilized plasma reconstituted with ascorbic acid suppresses inflammation and oxidative DNA damage. J Trauma. 2011;71(1):20–5.PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    McCully S, Lee T, McCully B, Sands C, Rick E, Dean R, et al. Reconstitution fluid type does not affect pulmonary inflammation or DNA damage following infusion of lyophilized plasma. J Trauma Acute Care Surg. 2015;78(2):231–9.PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Lee T, McCully S, McCully B, Sands C, Hampton D, Louis S, et al. Comparison of the hemostatic efficacy of low-volume lyophilized plasma reconstituted using sterile water, lactated Ringer’s, normal saline, and Hextend solutions. J Trauma Acute Care Surg. 2014;76(2):264–72.PubMedCrossRefPubMedCentralGoogle Scholar
  60. 60.
    Matijevic N, Wang Y, Cotton B, Hartwell E, Barbeau J, Wade C, et al. Better hemostatic profiles of never-frozen liquid plasma compared with thawed fresh frozen plasma. J Trauma Acute Care Surg. 2013;74(1):84–91.PubMedCrossRefGoogle Scholar
  61. 61.
    Matijevic N, Kostousov V, Wang Y, Wade C, Wang W, Letourneau P, et al. Multiple levels of degradation diminish hemostatic potential of thawed plasma. J Trauma. 2011;70(1):71–80.PubMedPubMedCentralCrossRefGoogle Scholar
  62. 62.
    Pati S, Matijevic N, Doursout M, Ko T, Cao Y, Deng X, et al. Protective effects of fresh frozen plasma on vascular endothelial permeability, coagulation, and resuscitation after hemorrhagic shock are time dependent and diminish between days 0 and 5 after thaw. J Trauma. 2010;69(Supplement):S55–63.PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Lee T, Watson K, Fabricant L, Barton J, Differding J, Kremenevskiy I, et al. Hyperosmolar reconstituted lyophilized plasma is an effective low-volume hemostatic resuscitation fluid for trauma. J Trauma Acute Care Surg. 2013;75(3):369–75.PubMedCrossRefGoogle Scholar
  64. 64.
    Shuja F, Finkelstein R, Fukudome E, Duggan M, Kheirbek T, Hamwi K, et al. Development and testing of low-volume hyperoncotic, hyperosmotic spray-dried plasma for the treatment of trauma-associated coagulopathy. J Trauma. 2011;70(3):664–71.PubMedCrossRefGoogle Scholar
  65. 65.
    Heiden M, Seitz R. Quality of therapeutic plasma—requirements for marketing authorization. Thromb Res. 2002;107:S47–51.PubMedCrossRefGoogle Scholar
  66. 66.
    Shuja F, Shults C, Duggan M, Tabbara M, Butt M, Fischer T, et al. Development and testing of freeze-dried plasma for the treatment of trauma-associated coagulopathy. J Trauma. 2008;65(5):975–85.PubMedCrossRefGoogle Scholar
  67. 67.
    Spinella P, Frazier E, Pidcoke H, Dietzen D, Pati S, Gorkun O, et al. All plasma products are not created equal. J Trauma Acute Care Surg. 2015;78:S18–25.PubMedCrossRefGoogle Scholar
  68. 68.
    Dombrose F, Barnes C, Gaynor J, Elston RA. Lyophilized human reference plasma for coagulation factors: evidence for stability of factors I, II, V, and VII through XII. Am J Clin Pathol. 1982;77(1):32–45.PubMedCrossRefGoogle Scholar
  69. 69.
    Fu P, Myhre B. Chemical analysis of a 30-year-old bottle of lyophilized plasma. Transfusion. 1977;17(1):73–4.PubMedCrossRefGoogle Scholar
  70. 70.
    Alam H, Hamwi K, Duggan M, Fikry K, Lu J, Fukudome E, et al. Hemostatic and pharmacologic resuscitation: results of a long-term survival study in a swine polytrauma model. J Trauma. 2011;70(3):636–45.PubMedCrossRefPubMedCentralGoogle Scholar
  71. 71.
    Pati S, Peng Z, Wataha K, Miyazawa B, Potter D, Kozar R. Lyophilized plasma attenuates vascular permeability, inflammation and lung injury in hemorrhagic shock. PLoS One. 2018;13(2):e0192363.PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Wataha K, Menge T, Deng X, Shah A, Bode A, Holcomb J, et al. Spray-dried plasma and fresh frozen plasma modulate permeability and inflammation in vitro in vascular endothelial cells. Transfusion. 2013;53:80S–90S.PubMedCrossRefPubMedCentralGoogle Scholar
  73. 73.
    Potter D, Baimukanova G, Keating S, Deng X, Chu J, Gibb S, et al. Fresh frozen plasma and spray-dried plasma mitigate pulmonary vascular permeability and inflammation in hemorrhagic shock. J Trauma Acute Care Surg. 2015;78:S7–S17.PubMedCrossRefPubMedCentralGoogle Scholar
  74. 74.
    Imam A, Jin G, Sillesen M, Duggan M, Jepsen C, Hwabejire J, et al. Early treatment with lyophilized plasma protects the brain in a large animal model of combined traumatic brain injury and hemorrhagic shock. J Trauma Acute Care Surg. 2013;75(6):976–83.PubMedCrossRefPubMedCentralGoogle Scholar
  75. 75.
    Halaweish I, Bambakidis T, Nikolian V, Georgoff P, Bruhn P, Piascik P, et al. Early resuscitation with lyophilized plasma provides equal neuroprotection compared with fresh frozen plasma in a large animal survival model of traumatic brain injury and hemorrhagic shock. J Trauma Acute Care Surg. 2016;81(6):1080–7.PubMedCrossRefPubMedCentralGoogle Scholar
  76. 76.
    Georgoff P, Nikolian V, Halaweish I, Chtraklin K, Bruhn P, Eidy H, et al. Resuscitation with lyophilized plasma is safe and improves neurological recovery in a long-term survival model of swine subjected to traumatic brain injury, hemorrhagic shock, and polytrauma. J Neurotrauma. 2017;34(13):2167–75.PubMedCrossRefPubMedCentralGoogle Scholar
  77. 77.
    DoD advances development of freeze-dried plasma for battlefield deployment: U.S. medicine [Internet]. 2018 [cited 27 March 2018]. Available from:
  78. 78.
    Gokhale S, Scorer T, Doughty H. Freedom from frozen: the first British military use of lyophilised plasma in forward resuscitation. J R Army Med Corps. 2014;162(1):63–5.PubMedCrossRefPubMedCentralGoogle Scholar
  79. 79.
    Pusateri A, Given M, Macdonald V, Homer M. Comprehensive US government program for dried plasma development. Transfusion. 2016;56:S16–23.PubMedCrossRefGoogle Scholar
  80. 80.
    Sunde G, Vikenes B, Strandenes G, Flo K, Hervig T, Kristoffersen E, et al. Freeze dried plasma and fresh red blood cells for civilian prehospital hemorrhagic shock resuscitation. J Trauma Acute Care Surg. 2015;78:S26–30.PubMedCrossRefPubMedCentralGoogle Scholar
  81. 81.
    Gellerfors M, Linde J, Gryth D. Helicopter in-flight resuscitation with freeze-dried plasma of a patient with a high-velocity gunshot wound to the neck in Afghanistan – a case report. Prehosp Disaster Med. 2015;30(05):509–11.PubMedCrossRefPubMedCentralGoogle Scholar
  82. 82.
    Glassberg E, Nadler R, Gendler S, Abramovich A, Spinella P, Gerhardt R, et al. Freeze-dried plasma at the point of injury: from concept to doctrine. Shock. 2013;40(6):444–50.PubMedPubMedCentralCrossRefGoogle Scholar
  83. 83.
    Glassberg E, Nadler R, Rasmussen T, Abramovich A, Erlich T, Blackbourne L, et al. Point-of-injury use of reconstituted freeze-dried plasma as a resuscitative fluid: a special report for prehospital trauma care. J Trauma Acute Care Surg. 2013;75:S111–4.PubMedCrossRefPubMedCentralGoogle Scholar
  84. 84.
    Shlaifer A, Siman-Tov M, Radomislensky I, Peleg K, Shina A, Baruch E, et al. Prehospital administration of freeze-dried plasma, is it the solution for trauma casualties? J Trauma Acute Care Surg. 2017;83(4):675–82.PubMedPubMedCentralCrossRefGoogle Scholar
  85. 85.
    Daban J, Clapson P, Ausset S, Deshayes A, Sailliol A. Freeze dried plasma: a French army specialty. Crit Care. 2010;14(2):412.PubMedPubMedCentralCrossRefGoogle Scholar
  86. 86.
    Martinaud C, Ausset S, Deshayes A, Cauet A, Demazeau N, Sailliol A. Use of freeze-dried plasma in French intensive care unit in Afghanistan. J Trauma. 2011;71(6):1761–5.PubMedPubMedCentralGoogle Scholar
  87. 87.
    Nguyen C, Bordes J, Cungi P, Esnault P, Cardinale M, Mathais Q, et al. Use of French lyophilized plasma transfusion in severe trauma patients is associated with an early plasma transfusion and early transfusion ratio improvement. J Trauma Acute Care Surg. 2018;84:780–5.PubMedCrossRefGoogle Scholar
  88. 88.
    Garrigue D, Godier A, Glacet A, Labreuche J, Kipnis E, Paris C, et al. French lyophilized plasma versus fresh frozen plasma for the initial management of trauma-induced coagulopathy: a randomized open-label trial. J Thromb Haemost. 2018;16(3):481–9.PubMedCrossRefGoogle Scholar
  89. 89.
    The safety of autologous lyophilized plasma versus fresh frozen plasma in healthy volunteers – full text view – [Internet]. 2018 [cited 27 March 2018]. Available from:
  90. 90.
    Ascending doses of autologous FDP vs FFP – full text view – [Internet]. 2018 [cited 27 March 2018]. Available from:
  91. 91.
    Teleflex [TFX] announces commencement of Phase I clinical study [FDP-1] of RePlas™ freeze-dried plasma | Teleflex incorporated [Internet]. Teleflex incorporated. 2018 [cited 27 March 2018]. Available from:
  92. 92.
    Resusix™ fresh frozen plasma [FFP] hemostatic volume resuscitation therapeutic | Entegrion [Internet]. 2018 [cited 27 March 2018]. Available from:
  93. 93.
    Safety study of spray-dried solvent/detergent-treated plasma for infusion in healthy volunteers – full text view – [Internet]. 2018 [cited 27 March 2018]. Available from:
  94. 94.
    Velico Medical announces BARDA exercise of $15.5 million contract option – Velico Medical [Internet]. 2018 [cited 27 March 2018]. Available from:
  95. 95.
    Perriello B. Velico Medical raises another $19m for Frontline ODP spray-dried plasma – MassDevice [Internet]. MassDevice. 2018 [cited 27 March 2018]. Available from:

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Mouayyad Zaza
    • 1
  • Kyle J. Kalkwarf
    • 1
  • John B. Holcomb
    • 1
  1. 1.Department of Surgery, Division of Acute Care SurgeryUniversity of Texas Health Science Center at Houston, Memorial Hermann HospitalHoustonUSA

Personalised recommendations